Genetic Signatures | GSS - Ebit

Stock Price
0.12
Daily Change
-0.01 -8.00%
Monthly
-32.35%
Yearly
-79.82%
Q1 Forecast
0.12

Genetic Signatures reported AUD-7.57M in EBIT for its fiscal semester ending in June of 2023.





Ebit Change Date
Avita Medical AUD -8.66M 1.61M Jun/2025
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
Starpharma Holdings AUD -1.03M 6.36M Dec/2023
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025